197 related articles for article (PubMed ID: 28235401)
1. Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer.
Chevrier M; Bobbala D; Villalobos-Hernandez A; Khan MG; Ramanathan S; Saucier C; Ferbeyre G; Geha S; Ilangumaran S
BMC Cancer; 2017 Feb; 17(1):157. PubMed ID: 28235401
[TBL] [Abstract][Full Text] [Related]
2. Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21(CIP1/WAF1) in the liver.
Yeganeh M; Gui Y; Kandhi R; Bobbala D; Tobelaim WS; Saucier C; Yoshimura A; Ferbeyre G; Ramanathan S; Ilangumaran S
Oncogene; 2016 Aug; 35(32):4200-11. PubMed ID: 26725321
[TBL] [Abstract][Full Text] [Related]
3. SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma.
Villalobos-Hernandez A; Bobbala D; Kandhi R; Khan MG; Mayhue M; Dubois CM; Ferbeyre G; Saucier C; Ramanathan S; Ilangumaran S
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):36-47. PubMed ID: 27779203
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of miR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression.
Zhang X; Liu J; Zang D; Wu S; Liu A; Zhu J; Wu G; Li J; Jiang L
Oncotarget; 2015 Jun; 6(17):15180-93. PubMed ID: 25893382
[TBL] [Abstract][Full Text] [Related]
5. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma.
Khan MGM; Ghosh A; Variya B; Santharam MA; Ihsan AU; Ramanathan S; Ilangumaran S
BMC Cancer; 2020 Aug; 20(1):774. PubMed ID: 32807134
[TBL] [Abstract][Full Text] [Related]
7. Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.
Gui Y; Yeganeh M; Donates YC; Tobelaim WS; Chababi W; Mayhue M; Yoshimura A; Ramanathan S; Saucier C; Ilangumaran S
Oncogene; 2015 Nov; 34(46):5718-28. PubMed ID: 25728680
[TBL] [Abstract][Full Text] [Related]
8. Identification of miR-30d as a novel prognostic maker of prostate cancer.
Kobayashi N; Uemura H; Nagahama K; Okudela K; Furuya M; Ino Y; Ito Y; Hirano H; Inayama Y; Aoki I; Nagashima Y; Kubota Y; Ishiguro H
Oncotarget; 2012 Nov; 3(11):1455-71. PubMed ID: 23231923
[TBL] [Abstract][Full Text] [Related]
9. Tumour-promoting role of SOCS1 in colorectal cancer cells.
Tobelaim WS; Beaurivage C; Champagne A; Pomerleau V; Simoneau A; Chababi W; Yeganeh M; Thibault P; Klinck R; Carrier JC; Ferbeyre G; Ilangumaran S; Saucier C
Sci Rep; 2015 Sep; 5():14301. PubMed ID: 26391193
[TBL] [Abstract][Full Text] [Related]
10. [Significance and expression of p53, p21(Cip1/WAF1) and Gadd45α in breast neoplasm tissues].
Gao QZ; Fei BJ; Qi XW; Pu Y; Feng YZ
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(34):2389-93. PubMed ID: 23158659
[TBL] [Abstract][Full Text] [Related]
11. The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms.
Kovacevic Z; Sivagurunathan S; Mangs H; Chikhani S; Zhang D; Richardson DR
Carcinogenesis; 2011 May; 32(5):732-40. PubMed ID: 21398495
[TBL] [Abstract][Full Text] [Related]
12. The association of p21((WAF-1/CIP1)) with progression to androgen-independent prostate cancer.
Fizazi K; Martinez LA; Sikes CR; Johnston DA; Stephens LC; McDonnell TJ; Logothetis CJ; Trapman J; Pisters LL; Ordoñez NG; Troncoso P; Navone NM
Clin Cancer Res; 2002 Mar; 8(3):775-81. PubMed ID: 11895908
[TBL] [Abstract][Full Text] [Related]
13. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
[TBL] [Abstract][Full Text] [Related]
14. Expression of p21 cell cycle protein is an independent predictor of response to salvage radiotherapy after radical prostatectomy.
Rigaud J; Tiguert R; Decobert M; Hovington H; Latulippe E; Laverdiere J; Larue H; Lacombe L; Fradet Y
Prostate; 2004 Feb; 58(3):269-76. PubMed ID: 14743466
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
16. Glyoxalase 2 drives tumorigenesis in human prostate cells in a mechanism involving androgen receptor and p53-p21 axis.
Antognelli C; Ferri I; Bellezza G; Siccu P; Love HD; Talesa VN; Sidoni A
Mol Carcinog; 2017 Sep; 56(9):2112-2126. PubMed ID: 28470764
[TBL] [Abstract][Full Text] [Related]
17. SOCS1 in cancer: An oncogene and a tumor suppressor.
Beaurivage C; Champagne A; Tobelaim WS; Pomerleau V; Menendez A; Saucier C
Cytokine; 2016 Jun; 82():87-94. PubMed ID: 26811119
[TBL] [Abstract][Full Text] [Related]
18. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.
Zlotta AR; Noel JC; Fayt I; Drowart A; Van Vooren JP; Huygen K; Simon J; Schulman CC
J Urol; 1999 Mar; 161(3):792-8. PubMed ID: 10022686
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Factors of Prostate Cancer in Tunisian Men: Immunohistochemical Study.
Missaoui N; Abdelkarim SB; Mokni M; Hmissa S
Asian Pac J Cancer Prev; 2016; 17(5):2655. PubMed ID: 27268646
[TBL] [Abstract][Full Text] [Related]
20. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]